Chen Xin-Ping, Wen Hai-Feng, Zhang Fan, Xu Wei-Hua, Ma Zhi-Chao, Fu Sheng-Miao
Clin Lab. 2017 Apr 1;63(4):725-731. doi: 10.7754/Clin.Lab.2016.161023.
Although various individual studies have been conducted to determine the association between X-ray repair cross-complementing group 1 (XRCC1) Arg399Gln polymorphism and breast cancer, the results remain inconclusive. To assess the influence of XRCC1 Arg399Gln polymorphism on the risk of breast cancer, a metaanalysis was performed in a single ethnic group.
Eligible studies were identified via databases such as PubMed, Springer Link, Ovid, Chinese Wanfang Data Knowledge Service Platform, Chinese National Knowledge Infrastructure, and Chinese Biology Medicine, throughout February 2016. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were used to assess the strengths of the associations.
Ten studies documenting a total of 4732 breast cancer cases and 5677 controls were included in this metaanalysis. The results indicated no significant association between XRCC1 Arg399Gln polymorphism and breast cancer risk in both total analysis and subgroup analysis stratified by geographical areas and source of controls.
This meta-analysis provided evidence that XRCC1 Arg399Gln variant might not be risk alleles for breast cancer susceptibility in the Chinese population. Further studies conducted in other ethnic groups are required for definite conclusions.
尽管已开展多项个体研究来确定X射线修复交叉互补基因1(XRCC1)的精氨酸399谷氨酰胺多态性与乳腺癌之间的关联,但其结果仍无定论。为评估XRCC1精氨酸399谷氨酰胺多态性对乳腺癌风险的影响,我们在单一民族群体中进行了一项荟萃分析。
通过PubMed、Springer Link、Ovid、中国万方数据知识服务平台、中国知网和中国生物医学数据库等,检索2016年2月之前符合条件的研究。采用合并比值比(OR)和95%置信区间(CI)来评估关联强度。
本荟萃分析纳入了10项研究,共涉及4732例乳腺癌病例和5677例对照。结果表明,在总体分析以及按地理区域和对照来源分层的亚组分析中,XRCC1精氨酸399谷氨酰胺多态性与乳腺癌风险之间均无显著关联。
本荟萃分析表明,在中国人群中,XRCC1精氨酸399谷氨酰胺变异可能不是乳腺癌易感性的风险等位基因。需要在其他民族群体中开展进一步研究以得出明确结论。